Richard D Kennedy - Dana-Farber Cancer Institute, Harvard Medical School

基本信息

Career Trajectory

Bio

Richard D Kennedy currently works at Almac Group / Queen's University Belfast. He specialises in Biomarker discovery, development and delivery under EU and US regulations for clinical trials. He has a particular interest in the Fanconi Anaemia/BRCA pathway and it’s role in the response to chemotherapy and immune checkpoint targeted agents.

Research Interests

Papers共 260 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis Through AhR/ROS/ATR Signaling Axis Modulation

Daryl Griffin,Robbie Carson, Debbie Moss,Tamas Sessler,Deborah Lavin,Vijay K Tiwari,Shivaali Karelia,Richard Kennedy,Kienan I Savage,Simon McDade,Adam Carie,Jim Pankovich,Mark Bazett,Sandra Van Schaeybroeck

Molecular cancer research MCR（2024）

Cited0Views0WOSBibtex

An Investigation of the Clinical Impact and Therapeutic Relevance of a DNA Damage Immune Response (DDIR) Signature in Patients with Advanced Gastroesophageal Adenocarcinoma

M. A. Baxter,L. C. Spender,D. Cairns, S. Walsh, R. Oparka, R. J. Porter, S. Bray, G. Skinner, S. King, J. Turbitt, D. Collinson, Z. H. Miedzybrodzka, G. Jellema, G. Logan,R. D. Kennedy,R. C. Turkington,M. H. Mclean,D. Swinson,H. I. Grabsch,S. Lord, M. J. Seymour,P. S. Hall,R. D. Petty

ESMO OPENno. 5 (2024)

Cited0Views0WOSBibtex

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

Shane R. Stecklein,William Barlow,Lajos Pusztai,Kirsten Timms,Richard Kennedy,Gemma E. Logan,Rob Seitz,Sunil Badve,Yesim Gokmen-Polar,Peggy Porter,Hannah Linden,Debu Tripathy,Gabriel N. Hortobagyi,Andrew K. Godwin,Alastair Thompson,Daniel F. Hayes,Priyanka Sharma

JCO PRECISION ONCOLOGY (2023)

Cited0Views0WOSBibtex

Data from Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM

Nuala McCabe,Conor Hanna,Steven M. Walker,David Gonda,Jie Li,Katarina Wikstrom,Kienan I. Savage,Karl T. Butterworth,Clark Chen,D. Paul Harkin,Kevin M. Prise,Richard D. Kennedy

crossref（2023）

Cited0Views0Bibtex

STAT3/LKB1 Controls Metastatic Prostate Cancer by Regulating Mtorc1/creb Pathway

Jan Pencik,Cecile Philippe,Michaela Schlederer,Emine Atas,Matteo Pecoraro,Sandra Grund-Gröschke,Wen (Jess) Li,Amanda Tracz,Isabel Heidegger,Sabine Lagger,Karolína Trachtová,Monika Oberhuber,Ellen Heitzer,Osman Aksoy,Heidi A. Neubauer,Bettina Wingelhofer,Anna Orlova,Nadine Witzeneder,Thomas Dillinger,Elisa Redl,Georg Greiner,David D’Andrea,Johnny R. Östman,Simone Tangermann,Ivana Hermanova,Georg Schäfer,Felix Sternberg,Elena E. Pohl,Christina Sternberg,Adam Varady,Jaqueline Horvath,Dagmar Stoiber,Tim I. Malcolm,Suzanne D. Turner,Eileen E. Parkes,Brigitte Hantusch,Gerda Egger,Stefan Rose-John,Valeria Poli,Suneil Jain,Chris W. D. Armstrong,Gregor Hoermann, Vincent Goffin,Fritz Aberger,Richard Moriggl,Arkaitz Carracedo,Cathal McKinney,Richard D. Kennedy,Helmut Klocker,Michael R. Speicher,Dean G. Tang,Ali A. Moazzami,David M. Heery,Marcus Hacker,Lukas Kenner

Molecular Cancerno. 1 (2023)

Cited0Views0WOSBibtex

Supplementary Figure 4 from PDLIM2 is a Marker of Adhesion and Β-Catenin Activity in Triple-Negative Breast Cancer

Orla T. Cox,Shelley J. Edmunds,Katja Simon-Keller, Bo Li,Bruce Moran,Niamh E. Buckley,Milan Bustamante-Garrido,Nollaig Healy,Ciara H. O'Flanagan,William M. Gallagher,Richard D. Kennedy,René Bernards,Carlos Caldas,Suet-Feung Chin,Alexander Marx,Rosemary O'Connor

crossref（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn